Kaye Scholer Advises Novartis on R&D Agreement with University of Pennsylvania to Study T-Cell Technology To Treat Cancer
Kaye Scholer is advising long-time client Novartis on its agreement for an exclusive global collaboration with University of Pennsylvania (Penn) to research, develop and commercialize targeted chimeric antigen receptor (CAR) immunotherapies for the treatment of cancers. In addition, the parties will jointly establish a new research and development facility on the Penn campus, called the Center for Advanced Cellular Therapies (CACT). Under the terms of the agreement, Penn grants Novartis an exclusive worldwide license to CARs developed through the collaboration for all indications. In addition Novartis will provide an up-front payment, research funding, funding for the establishment of the CACT and milestone payments for the achievement of certain clinical, regulatory and commercial milestones and royalty payments.
Led by Kaye Scholer Partner Adam Golden, Co-Chair of the firm’s Corporate Department, the other lawyers advising Novartis include IP Partner David Barr, Corporate Partner Andres Liivak, and Associates Holly Holloway and Viktoriya Karshenboyem, all out of the firm’s New York office.
Also of Interest
- Culhane Quoted in Private Funds Management on Fund-Related Legal Fees October 25, 2016 • Media Mentions
- Benchmark Litigation Recognizes Kaye Scholer Practices and Partners Nationwide October 24, 2016 • Recognitions
- SEC Issues Pay Ratio CDIs October 20, 2016 • Client Alerts
- Maier Plans Emergency Response with Fort Meade and Fort Detrick Commanders October 20, 2016 • Client Successes
- IFLR1000 Recognizes Kaye Scholer’s Global Presence, Practices and Lawyers October 19, 2016 • Recognitions
- Winning the War: Strategies for Prevailing in Consumer Fraud and False Advertising... October 17, 2016 • Articles
- Kaye Scholer Clients Achieve Nearly Full Recovery in Arch Coal Chapter 11 Proceeding October 14, 2016 • Client Successes
- Consumer Products in the Age of Big Data October 4, 2016 • Articles
- Shape of Things to Come: Protecting Product Configuration and Packaging Design September 26, 2016 • Articles